Synapse

← Sophia Zoungas

Papers by Sophia Zoungas

Page 4 · newest first

  1. Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trialContemporary Clinical Trials Communications · 2018
  2. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)Cardiovascular Diabetology · 2018
  3. Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016Scientific Reports · 2018
  4. A1C Targets Should Be Personalized to Maximize Benefits While Limiting RisksDiabetes Care · 2018
  5. Younger people with Type 2 diabetes have poorer self‐care practices compared with older people: results from the Australian National Diabetes AuditDiabetic Medicine · 2018
  6. Patterns of statin use and long‐term adherence and persistence among older adults with diabetesJournal of Diabetes · 2018
  7. Geographical variation of diabetic emergencies attended by prehospital Emergency Medical Services is associated with measures of ethnicity and socioeconomic statusSHILAP Revista de lepidopterología · 2018
  8. A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 YearsThe Journals of Gerontology Series A · 2018
  9. Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONDiabetes Care · 2017
  10. Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional studyBMJ Open · 2017
  11. Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysisThe Journals of Gerontology Series A · 2017
  12. Diabetes and Hypertension: A Position Statement by the American Diabetes AssociationDiabetes Care · 2017
  13. Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational studyPLoS ONE · 2017
  14. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesCardiovascular Diabetology · 2017
  15. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2017
  16. The association between patient activation and self‐care practices: A cross‐sectional study of an Australian population with comorbid diabetes and chronic kidney diseaseHealth Expectations · 2017
  17. Time series modelling to forecast prehospital EMS demand for diabetic emergenciesBMC Health Services Research · 2017
  18. Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic ReviewJMIR Research Protocols · 2017
  19. Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional studyBMC Nephrology · 2017
  20. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipientsCochrane library · 2017
  21. Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney DiseasePLoS ONE · 2016
  22. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceTyöväentutkimus Vuosikirja · 2016
  23. Individual, social and environmental factors and their association with weight in rural‐dwelling womenAustralian and New Zealand Journal of Public Health · 2016
  24. Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusCirculation · 2016
  25. Predicting 6-month mortality risk of patients commencing dialysis treatment for end-stage kidney diseaseNephrology Dialysis Transplantation · 2016
  26. Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 DiabetesDiabetes Care · 2016
  27. Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomesAustralian and New Zealand Journal of Obstetrics and Gynaecology · 2016
  28. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON studyCardiovascular Diabetology · 2016
  29. Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetesDiabetologia · 2016
  30. Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic controlThe Medical Journal of Australia · 2016
  31. Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesDiabetes Care · 2016
  32. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studiesBMC Cancer · 2016
  33. Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods explorationFamily Practice · 2016
  34. Interventions for lowering plasma homocysteine levels in dialysis patientsCochrane library · 2016
  35. Primary and tertiary health professionals’ views on the health-care of patients with co-morbid diabetes and chronic kidney disease – a qualitative studyBMC Nephrology · 2016
  36. Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONDiabetes Care · 2016
  37. Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetesJournal of Hypertension · 2016
  38. The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative StudyPLoS ONE · 2016
  39. How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patientsNephrology · 2015
  40. Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 DiabetesDiabetes Care · 2015
  41. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseCochrane library · 2015
  42. Effectiveness of management models for facilitating self-management and patient outcomes in adults with diabetes and chronic kidney diseaseSystematic Reviews · 2015
  43. The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approachClinical Endocrinology · 2015
  44. Interventions for lowering plasma homocysteine levels in kidney transplant recipientsCochrane library · 2015
  45. Prevalence of Infertility and Use of Fertility Treatment in Women with Polycystic Ovary Syndrome: Data from a Large Community-Based Cohort StudyJournal of Women s Health · 2015
  46. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With ObesityAmerican Journal of Hypertension · 2014
  47. A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes SocietyThe Medical Journal of Australia · 2014
  48. Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusHypertension · 2014
  49. Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 DiabetesNew England Journal of Medicine · 2014
  50. Effectiveness and implementation of an obesity prevention intervention: the HeLP-her Rural cluster randomised controlled trialBMC Public Health · 2014